New legislation introduced to the House and Senate seeks to bar the United States from funding Chinese biotechnology companies that could pose a risk to national security. The BIOSECURE Act would restrict federally funded medical providers from using products
New legislation introduced to the House and Senate seeks to bar the United States from funding Chinese biotechnology companies that could pose a risk to national security. The BIOSECURE Act would restrict federally funded medical providers from using products